394 related articles for article (PubMed ID: 17640385)
1. Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease.
Wolozin B; Wang SW; Li NC; Lee A; Lee TA; Kazis LE
BMC Med; 2007 Jul; 5():20. PubMed ID: 17640385
[TBL] [Abstract][Full Text] [Related]
2. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
3. Comparison of cardiovascular event rates in patients without cardiovascular disease in whom atorvastatin or simvastatin was newly initiated.
Jacobson TA; Wertz DA; Hoy T; Kuznik A; Grochulski D; Cziraky M
Mayo Clin Proc; 2008 Dec; 83(12):1316-25. PubMed ID: 19046550
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin therapy: a large database analysis of managed care plans in the United States.
Foody JM; Joyce AT; Rudolph AE; Liu LZ; Benner JS
Clin Ther; 2008 Jan; 30(1):195-205. PubMed ID: 18343257
[TBL] [Abstract][Full Text] [Related]
5. Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care.
Harley CR; Gandhi SK; Heien H; McDonough K; Nelson SP
Expert Opin Pharmacother; 2008 Apr; 9(5):669-76. PubMed ID: 18345946
[TBL] [Abstract][Full Text] [Related]
6. The association between statins and cancer incidence in a veterans population.
Farwell WR; Scranton RE; Lawler EV; Lew RA; Brophy MT; Fiore LD; Gaziano JM
J Natl Cancer Inst; 2008 Jan; 100(2):134-9. PubMed ID: 18182618
[TBL] [Abstract][Full Text] [Related]
7. Drug utilization patterns and cardiovascular outcomes in elderly patients newly initiated on atorvastatin or simvastatin.
Swindle JP; Potash J; Kulakodlu M; Kuznik A; Buikema A
Am J Geriatr Pharmacother; 2011 Dec; 9(6):471-82. PubMed ID: 22019005
[TBL] [Abstract][Full Text] [Related]
8. A large observational study of cardiovascular outcomes associated with atorvastatin or simvastatin therapy in hypertensive patients without prior cardiovascular disease.
Foody JM; Joyce AT; Jeffers BW; Liu LZ; Benner JS
Am J Ther; 2011; 18(2):110-6. PubMed ID: 20216383
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of statins for secondary prevention in elderly patients after acute myocardial infarction: an evaluation of class effect.
Zhou Z; Rahme E; Abrahamowicz M; Tu JV; Eisenberg MJ; Humphries K; Austin PC; Pilote L
CMAJ; 2005 Apr; 172(9):1187-94. PubMed ID: 15851712
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.
Heintjes EM; Penning-van Beest FJ; Plat AW; Meerding WJ; Webb K; Sturkenboom MC; Herings RM
Pharmacotherapy; 2012 Jul; 32(7):631-41. PubMed ID: 22760692
[TBL] [Abstract][Full Text] [Related]
11. Long-term use of statins reduces the risk of hospitalization for dementia.
Corrao G; Ibrahim B; Nicotra F; Zambon A; Merlino L; Pasini TS; Catapano AL; Mancia G
Atherosclerosis; 2013 Oct; 230(2):171-6. PubMed ID: 24075740
[TBL] [Abstract][Full Text] [Related]
12. Risk of diabetes in patients treated with HMG-CoA reductase inhibitors.
Cho Y; Choe E; Lee YH; Seo JW; Choi Y; Yun Y; Wang HJ; Ahn CW; Cha BS; Lee HC; Kang ES
Metabolism; 2015 Apr; 64(4):482-8. PubMed ID: 25312577
[TBL] [Abstract][Full Text] [Related]
13. Statins and stroke: current clinical practice.
Castilla-Guerra L; Espino-Montoro A; Fernandez Moreno Mdel C; López-Chozas JM; Jimérnez MD
Stroke; 2006 May; 37(5):1153. PubMed ID: 16556875
[No Abstract] [Full Text] [Related]
14. Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention.
Zhou Z; Rahme E; Pilote L
Am Heart J; 2006 Feb; 151(2):273-81. PubMed ID: 16442888
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms.
Kumar A; Sharma N; Gupta A; Kalonia H; Mishra J
Brain Res; 2012 Aug; 1471():13-22. PubMed ID: 22789904
[TBL] [Abstract][Full Text] [Related]
16. Comparing the efficacy and safety of atorvastatin and simvastatin in Asians with elevated low-density lipoprotein-cholesterol--a multinational, multicenter, double-blind study.
Wu CC; Sy R; Tanphaichitr V; Hin AT; Suyono S; Lee YT
J Formos Med Assoc; 2002 Jul; 101(7):478-87. PubMed ID: 12353340
[TBL] [Abstract][Full Text] [Related]
17. Statins in elderly patients with acute coronary syndrome: an analysis of dose and class effects in typical practice.
Choudhry NK; Levin R; Winkelmayer WC
Heart; 2007 Aug; 93(8):945-51. PubMed ID: 17344334
[TBL] [Abstract][Full Text] [Related]
18. Statins and prostate cancer diagnosis and grade in a veterans population.
Farwell WR; D'Avolio LW; Scranton RE; Lawler EV; Gaziano JM
J Natl Cancer Inst; 2011 Jun; 103(11):885-92. PubMed ID: 21498780
[TBL] [Abstract][Full Text] [Related]
19. LDL-C goal attainment in patients who remain on atorvastatin or switch to equivalent or non-equivalent doses of simvastatin: a retrospective matched cohort study in clinical practice.
Rublee DA; Burke JP
Postgrad Med; 2010 Mar; 122(2):16-24. PubMed ID: 20203452
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and cost-effectiveness of rosuvastatin, atorvastatin, and simvastatin among high-risk patients in usual clinical practice.
Ohsfeldt RL; Gandhi SK; Fox KM; Stacy TA; McKenney JM
Am J Manag Care; 2006 Nov; 12(15 Suppl):S412-23. PubMed ID: 17112329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
